Literature DB >> 18326692

Isolated ocular disease is associated with decreased mucolipin-1 channel conductance.

Ehud Goldin1, Rafael C Caruso, William Benko, Christine R Kaneski, Stephanie Stahl, Raphael Schiffmann.   

Abstract

PURPOSE: To evaluate a 15-year-old boy with MLIV (mucolipidosis type IV) and clinical abnormalities restricted to the eye who also had achlorhydria with elevated blood gastrin levels.
METHODS: In addition to a detailed neuro-ophthalmic and electrophysiological assessment, his mutant mucolipin-1 was experimentally expressed in liposomes and its channel properties studied in vitro.
RESULTS: The patient was a compound heterzygote for c.920delT and c.1615delG. Detailed neuro-ophthalmic examination including electroretinography showed him to have a typical retinal dystrophy predominantly affecting rod and bipolar cell function. In vitro expression of MCOLN1 in liposomes showed that the c.1615delG mutated channel had significantly reduced conductance compared with wild-type mucolipin-1, whereas the inhibitory effect of low pH and amiloride remained intact.
CONCLUSIONS: These findings suggest that reduced channel conductance is relatively well tolerated by the brain during development, whereas retinal cells and stomach parietal cells require normal protein function. MLIV should be considered in patients with retinal dystrophy of unknown cause and screened for using blood gastrin levels.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18326692      PMCID: PMC5267708          DOI: 10.1167/iovs.07-1649

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  19 in total

1.  Suppression of the cup-5 mucolipidosis type IV-related lysosomal dysfunction by the inactivation of an ABC transporter in C. elegans.

Authors:  Lara Schaheen; Greg Patton; Hanna Fares
Journal:  Development       Date:  2006-08-30       Impact factor: 6.868

2.  TRP-ML1 regulates lysosomal pH and acidic lysosomal lipid hydrolytic activity.

Authors:  Abigail A Soyombo; Sandra Tjon-Kon-Sang; Youssef Rbaibi; Enkelejda Bashllari; Jill Bisceglia; Shmuel Muallem; Kirill Kiselyov
Journal:  J Biol Chem       Date:  2005-12-16       Impact factor: 5.157

3.  Congenital corneal clouding with abnormal systemic storage bodies: a new variant of mucolipidosis.

Authors:  E R Berman; N Livni; E Shapira; S Merin; I S Levij
Journal:  J Pediatr       Date:  1974-04       Impact factor: 4.406

4.  Identification of the gene causing mucolipidosis type IV.

Authors:  R Bargal; N Avidan; E Ben-Asher; Z Olender; M Zeigler; A Frumkin; A Raas-Rothschild; G Glusman; D Lancet; G Bach
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

Review 5.  TRPpathies.

Authors:  Kirill Kiselyov; Abigail Soyombo; Shmuel Muallem
Journal:  J Physiol       Date:  2006-11-30       Impact factor: 5.182

6.  Noninvasive diagnosis and ophthalmic features of mucolipidosis type IV.

Authors:  Janine A Smith; Chi-Chao Chan; Ehud Goldin; Raphael Schiffmann
Journal:  Ophthalmology       Date:  2002-03       Impact factor: 12.079

7.  Mucolipidosis IV: report of a case with ocular restricted phenotype caused by leaky splice mutation.

Authors:  Robert Dobrovolny; Petra Liskova; Jana Ledvinova; Helena Poupetova; Befekadu Asfaw; Martin Filipec; Katerina Jirsova; Josef Kraus; Milan Elleder
Journal:  Am J Ophthalmol       Date:  2006-12-28       Impact factor: 5.258

8.  Reconstitution and characterization of a nicotinic acid adenine dinucleotide phosphate (NAADP)-sensitive Ca2+ release channel from liver lysosomes of rats.

Authors:  Fan Zhang; Pin-Lan Li
Journal:  J Biol Chem       Date:  2007-07-03       Impact factor: 5.157

9.  The neurogenetics of mucolipidosis type IV.

Authors:  G Altarescu; M Sun; D F Moore; J A Smith; E A Wiggs; B I Solomon; N J Patronas; K P Frei; S Gupta; C R Kaneski; O W Quarrell; S A Slaugenhaupt; E Goldin; R Schiffmann
Journal:  Neurology       Date:  2002-08-13       Impact factor: 9.910

10.  Cloning of the gene encoding a novel integral membrane protein, mucolipidin-and identification of the two major founder mutations causing mucolipidosis type IV.

Authors:  M T Bassi; M Manzoni; E Monti; M T Pizzo; A Ballabio; G Borsani
Journal:  Am J Hum Genet       Date:  2000-09-29       Impact factor: 11.025

View more
  10 in total

Review 1.  Lacritin and other autophagy associated proteins in ocular surface health.

Authors:  Roy Karnati; Venu Talla; Katherine Peterson; Gordon W Laurie
Journal:  Exp Eye Res       Date:  2015-08-25       Impact factor: 3.467

Review 2.  TRPMLs: in sickness and in health.

Authors:  Rosa Puertollano; Kirill Kiselyov
Journal:  Am J Physiol Renal Physiol       Date:  2009-01-21

3.  N-butyldeoxynojirimycin delays motor deficits, cerebellar microgliosis, and Purkinje cell loss in a mouse model of mucolipidosis type IV.

Authors:  Lauren C Boudewyn; Jakub Sikora; Ladislav Kuchar; Jana Ledvinova; Yulia Grishchuk; Shirley L Wang; Kostantin Dobrenis; Steven U Walkley
Journal:  Neurobiol Dis       Date:  2017-06-10       Impact factor: 5.996

Review 4.  Mucolipidosis type IV: an update.

Authors:  Kazuyo Wakabayashi; Ann Marie Gustafson; Ellen Sidransky; Ehud Goldin
Journal:  Mol Genet Metab       Date:  2011-06-16       Impact factor: 4.797

5.  Activating mutations of the TRPML1 channel revealed by proline-scanning mutagenesis.

Authors:  Xian-ping Dong; Xiang Wang; Dongbiao Shen; Su Chen; Meiling Liu; Yanbin Wang; Eric Mills; Xiping Cheng; Markus Delling; Haoxing Xu
Journal:  J Biol Chem       Date:  2009-07-28       Impact factor: 5.157

Review 6.  Current concepts in the neuropathogenesis of mucolipidosis type IV.

Authors:  Lauren C Boudewyn; Steven U Walkley
Journal:  J Neurochem       Date:  2018-08-30       Impact factor: 5.372

7.  Neuropathology of the Mcoln1(-/-) knockout mouse model of mucolipidosis type IV.

Authors:  Matthew C Micsenyi; Kostantin Dobrenis; Gloria Stephney; James Pickel; Marie T Vanier; Susan A Slaugenhaupt; Steven U Walkley
Journal:  J Neuropathol Exp Neurol       Date:  2009-02       Impact factor: 3.685

8.  Robust lysosomal calcium signaling through channel TRPML1 is impaired by lysosomal lipid accumulation.

Authors:  Néstor Más Gómez; Wennan Lu; Jason C Lim; Kirill Kiselyov; Keith E Campagno; Yulia Grishchuk; Susan A Slaugenhaupt; Bruce A Pfeffer; Steven J Fliesler; Claire H Mitchell
Journal:  FASEB J       Date:  2018-01-04       Impact factor: 5.834

Review 9.  Neuropathophysiology, Genetic Profile, and Clinical Manifestation of Mucolipidosis IV-A Review and Case Series.

Authors:  Aleksandra Jezela-Stanek; Elżbieta Ciara; Karolina M Stepien
Journal:  Int J Mol Sci       Date:  2020-06-26       Impact factor: 5.923

10.  Cross-sectional Observations on the Natural History of Mucolipidosis Type IV.

Authors:  Albert L Misko; Levi B Wood; Madeline DeBono; Rebecca Oberman; Annick Raas-Rothschild; Yulia Grishchuk; Florian Eichler
Journal:  Neurol Genet       Date:  2022-03-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.